Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pannoc is a Belgian pharmaceutical manufacturer specializing in the development, production, packaging, and sale of medicines (mainly topical), medical excipients/raw materials (especially ointment bases), cosmetics in various forms (creams, gels, lotions), and a limited number of medical devices. The company also offers private label manufacturing for third parties. It was acquired in 2023 by ACE Pharmaceuticals Belgium BV and Febelco CV but continues to operate under its own name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pannoc.